Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Illinois GI Practices Sign On to Harness Power of SonarMD

Leave a comment


SonarMD, the company leading value-based care enablement in digestive health, has signed new partnerships with gastroenterology practices in Illinois as part of an agreement with a major health plan in the state.

CHICAGO, Sept. 28, 2023 /PRNewswire-PRWeb/ — SonarMD, the company leading value-based care enablement in digestive health, has signed new partnerships with gastroenterology practices in Illinois as part of an agreement with a major health plan in the state.

SonarMD works collaboratively with practices to help them proactively manage the health of patients with inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — in between in-office appointments.

IBD patients at these practices who are members of the health plan will have free access to the easy-to-use SonarMD tool, which they can use to track their GI symptoms in the privacy of their own home. If the SonarMD program identifies a patient with worsening conditions, SonarMD assesses their needs and enables their own practices’ care teams to quickly address them — so patients can avoid an emergency room visit or hospital stay.

“We are excited to partner with SonarMD to enhance care for our patients in between office visits without adding to the workload of our staff,” said Rocky Yapp, MD, a gastroenterologist with Digestive Health Services, a division of GI Partners of Illinois and a practice newly using SonarMD. “Most importantly, we will be improving‥the quality of care for patients who suffer from this complex and challenging disease.”

The U.S. spends about $136 billion annually on digestive health, with much of that spend attributable to chronic gut health conditions with symptoms that are difficult to predict, treat, and manage. SonarMD’s solution is proven to prevent ER visits and hospitalizations among IBD patients.

“Innovative, value-focused health plans recognize that IBD is a chronic, complex condition with symptoms that can quickly escalate,” said Beth Houck, CEO, SonarMD. “That’s why they’re working with us to forge new partnerships with GI providers in their network. We’re giving GI practices the ability to closely track their patients’ progression, which can improve loyalty and outcomes while keeping patients out of high-cost sites of care.”

ABOUT SONARMD

SonarMD partners with health plans and GI practices in their network to enable value-based care. We use remote patient monitoring, algorithms and expert support to help GI practices proactively identify emerging health issues and address problems before they escalate to a hospitalization or visit to the emergency department. Our curated partnerships also support whole health, including emotional well-being, nutrition and sleep management. Our approach is proven to keep people healthier and help health plans reduce costs by 15% per member per year. Visit SonarMD.com to learn more.

Media Contact

Patty Keiler, SonarMD, 1 3125505394, [email protected], https://sonarmd.com

SOURCE SonarMD

Health

Labroots Announces its 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Series on October 3-5, 2023

Leave a comment


Attendees will learn firsthand about the latest breakthroughs in cancer research and emerging issues in oncology to improve patient care and outcomes

YORBA LINDA, Calif., Sept. 28, 2023 /PRNewswire-PRWeb/ — Yorba Linda, CA (September 28, 2023) –Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, is hosting its 11th annual Cancer Research & Immuno-Oncology Week conference on October 3-5, 2023, free to attend.

This meeting will bring together thousands of innovative research scholars, industry and patient advocates, scientists, clinicians, oncologists, healthcare professionals and leading academic experts to strengthen collaboration and explore opportunities for novel therapeutic advances in clinical oncology and cancer research. The three-day agenda includes educational and sponsored presentations on cutting-edge discoveries and key advancements in the field to improve the outcomes and treatments of patients with cancer.

Cancer Research & Immuno-Oncology Week 2023 continues to deliver a prestigious forum for some of the brightest minds in the fields of cancer research and immuno-oncology disciplines. Distinguished speakers will share their knowledge spanning topics including but not limited to, using genomics/genetics to influence clinical applications, image analysis in cancer research and treatment, cancer systems biology, informed consent in cancer research, combination and personalized therapies, new developments in pediatric cancer therapies, neoantigen vaccines, the microbiome in immuno-oncology, molecular targets to engage anticancer immunity, novel engineering strategies, cancer health disparities, and addressing inhibitory barriers in tumor microenvironment.

Naming a few program highlights:
Keynote speaker, Li-Ming Su, MD, FRCS, Secretary General, Endourological Society, Pete and Carolyn Newsome Professor of Urologic Oncology, Chair, Department of Urology, at the University of Florida College of Medicine will discuss ‘Advanced Imaging for Small Renal Tumors’ describing how new advanced imaging modalities may in the future help predict tumor phenotype and thus reduce the number of unnecessary treatments of benign or low risk renal tumors.

Dr. Li-Ming Su said, “Conventional imaging studies such as ultrasound, computed tomography, and magnetic resonance imaging are increasingly detecting small renal lesions, which are interpreted by radiologists as highly suspicious for renal cell cancer. However, up to 30% of these small solid tumors (4 cm) are in fact found to be benign on surgical excision. This highlights a significant limitation in conventional radiologic studies in sub-stratifying which patient require active treatment (i.e. surgery versus thermal ablation) versus surveillance. New imaging technologies such as advanced cross-sectional imaging, molecular imaging and optical imaging show promise in improving pre-treatment risk categorization with the hopes of reducing unnecessary treatment. The Labroots conference allows the sharing of ideas across scientific disciplines that will hopefully drive new approaches and innovation to challenges such as this.”

Keynote speaker Dr. Vipul Patel, Medical Director at AdventHealth and world-renowned for his contribution to the field of robotic-assisted surgery and has personally performed over 17,000 robotic prostatectomies will deliver a compelling presentation on the evolving paradigm of prostate cancer surgery: lessons learning from 17,000 RALP’s that have translated to significantly better patience care and outcomes.

Keynote speaker Dr. Curtis J. Henry, Deputy Associate Director of Diversity, Equity, Inclusion, and Access (DEIA), The University of Colorado Cancer Center, and Associate Professor of Immunology & Microbiology, The Margaret Turley Grohne Chair in Translational Cancer Research will share a presentation titled, ‘Delineating the Pleiotropic Impact of Obesity on T-cell Function and Immunotherapy Efficacy’ with a Live Q&A session.

Dr. Curtis J. Henry said, “I hate to use the dreaded “P” word; however, obesity has reached pandemic levels. Currently, over 300 million adults and 25 million children globally are classified as living with obesity, and mathematical projections indicate that, without interventions, these numbers will continue to increase for decades. Obesity has a multitude of negative impacts on health, with one being an increased chance of developing and succumbing to various solid and hematological malignancies. This connection is currently under investigation, with our group, and others, studying how obesity-induced immunological changes impact immunity and responses to immune-based therapies targeting cancers. I’m excited to share our work at the 11th annual Labroots Cancer Research & Immuno-Oncology Week conference where the invaluable discussions will help shape the nature of our studies moving forward.”

Produced on Labroots’ partnering virtual event platform Chati, attendees can connect seamlessly across all desktops and mobile devices while immersed in a one-stop educational experience. The interactive online environment features a lobby equipped with leaderboard and gamification, an auditorium, featuring live-streaming video webcasts offering live attendee chats during scheduled presentations, a poster hall complete with a poster competition, live chat conversations, plus a newly added feature – a scheduled Poster Networking Hour with live poster authors, an exhibit hall to interact with sponsors and view their recent contributions in the field, and a networking lounge to connect and collaborate with colleagues.

By participating in this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits. To register for the event, click here.

Use the hashtag #LRcancer to follow the conversation and connect with members of the global Cancer & Oncology Research community! Follow @Cancer_LR on Twitter and @CancerResearchandOncology.LR on Facebook to connect with our specialist Cancer & Oncology writers and stay up to date with the latest news in Cancer & Oncology Research.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected], www.labroots.com

Twitter

SOURCE Labroots



Health

Prevent Blindness Names Ed Buffington, GPN Technologies, as the 2024 Person of Vision Award Recipient

Leave a comment


Buffington began his career in the optical industry in 1979 as part of the contact lens company, American Hydron. In 1983, with his partners, he launched OfficeMate Software installing the first eyecare practice management software system to run on an IBM PC in April 1984.

After tremendous growth, in 1994, Marchon acquired OfficeMate, which was later acquired by VSP. Today OfficeMate remains one of the leading eyecare practice management and electronic medical records software solutions in the optometric industry with a significant market share.

After retiring from VSP in 2014, Buffington began his private consulting firm, The Buffington Company, leveraging his nearly 40 years of expertise in the eyecare industry. In 2017, Buffington joined data analytics firm, GPN Technologies as President and CEO.

“I am humbled and honored to receive this very special industry recognition from Prevent Blindness, thank you!” said Buffington. “I want to thank all the wonderful friends and partners I’ve worked with throughout my tenure in eyecare. It’s those relationships that have contributed to my success and enjoyment in my career.”

Additionally, at the Person of Vision Award gala, Prevent Blindness will celebrate the 50th Anniversary of 20/20 Magazine, a publication of Jobson Medical Information, LLC. The publication includes information and resources for optometrists and other eyecare industry professionals, featuring fashion trending, branding, style, lenses and technology, product news and continuing education.

“We are incredibly honored that Prevent Blindness will be recognizing the 50th Anniversary of 20/20 Magazine at the Person of Vision Dinner in March,” said James DeMatteis, Group Publisher, 20/20 and Vision Monday. “Achieving this milestone is something Jobson is both humbled by and very proud of—not only of the accomplishments this anniversary represents, but also of the tremendous strides the optical arena has achieved these past five decades.”

Maureen Cavanagh, Safilo, is once again serving as the 2024 Person of Vision Committee Chair. Additional committee members include Marge Axelrad, Vision Monday; Jay Binkowitz, Keplr Vision; Deb Bulken, Luxottica Wholesale; Marc Ferrera, Jobson Medical Information; Anne Kavanagh, Kavanagh Consulting LLC; Katie Lauver, GPN Technologies; Lorie Lippiatt, LLL Holdings, LLC; Prevent Blindness Board of Directors Chair Jim McGrann, Advancing Eyecare; and Matt Tackman, Essilor.

“We are proud to recognize Ed Buffington and 20/20 Magazine at the 2024 Person of Vision Award gala,” said Jeff Todd, president and CEO of Prevent Blindness. “Tickets will be selling quickly, so we encourage everyone to purchase their seats now and make sure they don’t miss out on this fantastic event!”

For more information, including sponsorship opportunities, Person of Vision Award committee membership, and tickets, please contact Albert Muci at (312) 363-6020 or [email protected], or visit https://preventblindness.org/personofvision.

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.

Media Contact

Sarah Hecker, Prevent Blindness, 312.363.6035, [email protected], PreventBlindness.org

Twitter

SOURCE Prevent Blindness



Health: Addiction

Bravado Designs Launches Rebrand & Expansion After 30 Years of Shaping Maternity and Nursing Wear Markets

Leave a comment


Bravado Designs provides thoughtful and beautiful designs for all momkind

TORONTO, Sept. 28, 2023 /PRNewswire-PRWeb/ — Bravado Designs, the globally recognized female designed legacy brand providing solutions to mothers at the start of their motherhood adventure with nursing and maternity products, is thrilled to announce an exciting rebranding initiative that marks a significant evolution in its 30-year journey. Bravado Designs introduces new styles, products, and limited edition designs to cater to moms throughout their motherhood adventures.

Bravado Designs proudly unveils its rebrand through a new logo, enhanced way of communicating with their consumers, and an invigorating look and feel, accompanying an incredible product line with fresh introductions regularly from this Fall of 2023 through 2025. Its 30 years experience has provided a deep understanding of the needs and bodies of Moms and, through Bravado’s technical expertise, is able to engineer thoughtfully and beautifully designed products that elevate both Momhood and the industry as a whole. The rebrand doesn’t just reflect outward facing communications, the brand has also taken a great deal of time and energy to enhance their brand positioning and re-write their core values and behaviors to ensure all employees and partners are leaning into the brand promise and living and breathing the values at every level, every day.

“We want Bravado Designs to resonate with Moms around the world, supporting them in their incredible motherhood journey,” says Nicole McCasey, President at Bravado Designs. “Our rich brand history has been reliable, but we knew that to move forward and truly support mothers everywhere, we needed to evolve. This rebrand and new products are our next step in servicing all of momkind at all stages of their adventure.”

Bravado Designs’ range of new product offerings not only continue Bravado’s commitment to nursing and maternity but, for the very first time, venture further into stages of the motherhood adventure including stylish and functional diaper and hospital tote bags. The brand remains dedicated to its core values and its commitment to creating exceptional products that celebrate the essence of motherhood.

For more information please visit https://bravadodesigns.com/

Bravado Designs

Bravado Designs is an iconic brand founded by two moms that couldn’t find a bra that both fit properly and also made them feel beautiful. This lead the brand to specialize in knowing how to technically and thoughtfully design bras for pregnant and nursing women. Never straying from its core offerings in 30 years, it’s safe to say the brand is made up of experts who know how a woman’s body changes and designs the bras to adapt accordingly. Every launch, adaptation and function is one for the core target, who is kept at the center of the brand. The brand has been featured in outlets such as The New York Times, Healthline, People, PopSugar and more.

Media Contact

Christine Joyce, Victory Public Relations, 1 2015720089, [email protected]

SOURCE Bravado Designs

Health

Fabre-Kramer Pharmaceuticals Announces FDA Approval of EXXUA™, the First and Only Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder in Adults

Leave a comment



EXXUA is the first new chemical entity (NCE) utilizing this single mechanism approved for the treatment of major depressive disorder. EXXUA’s approved labeling does not list sexual dysfunction as an adverse reaction. HOUSTON, Sept. 28, 2023 /PRNewswire/ — Fabre-Kramer Pharmaceuticals Inc….

Health

Ultra Marathon Swimmer Sarah Thomas Will Attempt 50-Mile Swim in Lake Mead from Colorado River to the Hoover Dam and Make Waves to Fight Cancer with Swim Across America

Leave a comment


  • Sarah Thomas is the first person to complete a four-way crossing of the English Channel in 54 hours and 10 minutes in 2019. She did so one year after completing treatments for breast cancer!
  • She holds the world record for the longest continuous (unassisted, non-wetsuit) swim done in current-neutral conditions. That record-breaking swim covered 104.6 miles over 67 hours in Lake Champlain (USA) in August of 2017.
  • She is the first person to complete a two-way crossing of the North Channel in 21 hours and 46 minutes in 2022. The North Channel is the body of water bounded by Northern Ireland (to the west), Scotland (to the east), Isle of Man (to the south), and the Atlantic Ocean (to the north).
  • She is the first person to complete a two-way swim of Lake Tahoe (lengthwise) in 2013. The swim is 42 miles and Sarah completed it in 22 hours and 30 minutes.

Though Sarah holds many records in open water swimming, in her words, she doesn’t swim to “be the first.” She swims large bodies of water because she loves seeing the beauty in each corner of the world.

“After my first visit to the Hoover Dam in February 2021, I knew I had to swim across Lake Mead,” said Sarah. “Water levels in the lake are in danger of dropping so low that a swim may not always be possible across this beautiful and important body of water.”

Sarah’s swim across Lake Mead will start in South Cove, where her favorite river, The Colorado, enters the lake. She will then follow the lake 50 miles until she runs out of water at the Hoover Dam.

Sarah hopes to raise money for Swim Across America through her monumental swims.

“I was diagnosed with stage two breast cancer in 2017 at the age of 35,” said Sarah. “It was a terrifying time and we didn’t know how much my treatments would impact my ability to swim in the future. Being able to partner with Swim Across America combines two of my passions: open water swimming and doing everything I can to fight cancer so that others won’t have to go through what I went through.”

Sarah has supported Swim Across America since 2018, when the inaugural Swim Across America – Denver swim was held in her home community. As a breast cancer survivor, she hopes to raise money for cancer research and bring hope and new treatment options to others.

“Cancer treatments tested me in a way I never thought possible,” noted Sarah. “Despite undergoing chemotherapy, surgery, and radiation therapy, I never gave up on my dream of doing a swim that most people thought was impossible.”

A year after completing treatments, she did the impossible – becoming the first person to complete a four-way crossing of the English Channel.

Swim Across America was founded in 1987 with its first open water event in Long Island Sound. Since that time, the nonprofit organization has raised more than $100 million to fight cancer. In its 36 years of “making waves to fight cancer,” more than 100,000 swimmers and 150 Olympians have swum the circumference of the earth three times, uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities hold open water swims and charity pool swims each year, from Nantucket to under the Golden Gate Bridge, which support innovative cancer research, detection and patient programs.

Swim Across America’s funding of clinical trials for patients helped contribute to four FDA approved life-saving immunotherapy cancer treatments: Yervoy, Opdivo, Tecentriq and Keytruda. In June of last year, a clinical trial at Memorial Sloan Kettering was published in The New England Journal of Medicine that showed a 100 percent success rate in treating patients in a phase 2 clinical trial for advanced rectal cancer with dostarlimab, an immunotherapy treatment produced by GlaxoSmithKline. The clinical trial at Memorial Sloan Kettering was funded by early-stage grant funding from Swim Across America. More than 60 scientific grants are funded each year and there are now ten dedicated Swim Across America Labs at major institutions including: Children’s Healthcare of Atlanta, John Hopkins Medicine Baltimore, Rush University Medical Center Chicago, Baylor Scott & White Charles A. Sammons Cancer Center in Dallas, Memorial Sloan Kettering Cancer Center New York, Infusion Center at Nantucket Cottage Hospital, UCSF Benioff Children’s Hospital Oakland and San Francisco, the Seattle Cancer Care Alliance, The Swim Across America Pediatric Research Lab at Columbia University Medical Center New York, and at Meyer Cancer Center at Weill Cornell Medicine.

To follow Sarah’s progress or support her cause, visit swimacrossamerica.org/sarahthomas.

Swim Across America, Inc. (SAA) is dedicated to raising money and awareness for cancer research, prevention and treatment through swimming-related events. With the help of hundreds of volunteers nationwide and past and current Olympians, Swim Across America is helping find a cure for cancer through athleticism, community outreach and direct service. To learn more visit swimacrossamerica.org or follow on Facebook @SwimAcrossAmerica or on Instagram or Twitter @SAASwim.

Media Contact

Jenifer Howard, Swim Across America, 1 203-273-4246, [email protected], http://www.swimacrossamerica.org

SOURCE Swim Across America

Health

Roland DGA’s DGSHAPE DWX-42W Plus Chairside Milling Solution Wins the 2023 Cellerant Best of Class Technology Award

Leave a comment


The DGSHAPE DWX-42W Plus is a next-generation Chairside Milling Solution incorporating technological enhancements that maximize overall efficiency, productivity, reliability, and ease of use. It boasts new features and capabilities that take performance and versatility to a higher level, including a newly designed spindle with a shaft wall that is approximately four times thicker than its predecessor’s, expanded material compatibility, and increased milling speed, precision, and quality. Further enhancing the DWX-42W mill’s accuracy and versatility is the wide selection of state-of-the-art milling tools available for this device, including ZGB tools for harder materials like Amber® Mill Direct, Powered by Roland DGA or fully sintered zirconia and ZGB2 tools for traditional glass ceramics, hybrid ceramics, and nano-composite materials. Powerful, user-friendly CAM Software, included with the DWX-42W, optimizes workflow by providing a host of useful tools and features, such as a quick mill option that lets you select frequently used materials and start milling quickly, a choice of fast or high-quality milling applications, Multiple Job Setup for significantly reduced milling times, and much more.

“Receiving a Cellerant Best of Class Technology Award is a tremendous honor, as it’s based on significant research by top experts within the field who thoroughly analyze and evaluate every aspect of the products under consideration,” said Jimmy Ruiz, Dental Business Manager at Roland DGA’s DGSHAPE Americas. “We’re thrilled, but not surprised, that the DWX-42W impressed the judging panel. It’s a truly innovative device that combines cutting-edge technology with unsurpassed ease of use and dependability to help any practice elevate its chairside-milling capabilities.”

For more information on the Cellerant Best of Class Awards and the 2023 award winners, visit https://www.cellerantconsulting.com/best-of-class-technology-2023. To learn more about the DWX-42W Plus wet dental mill or the complete DGSHAPE line of dental products and accessories, visit https://www.rolanddga.com/products/dental/dwx-series.

About Roland DGA Corporation and DGSHAPE Americas

Roland DGA Corporation serves North and South America as the marketing, sales, distribution and service arm for Roland DG Corporation and its subsidiary, DGSHAPE. Founded in 1981 and listed on the Tokyo Stock Exchange, Roland DG of Hamamatsu, Japan is a worldwide leader in wide-format inkjet printers, engravers, photo impact printers and CNC milling machines. DGSHAPE Americas is the Roland DGA dental business group dedicated to the DGSHAPE line of products, most notable as a market leader in dental milling machines.

Media Contact

Marc Malkin, Roland DGA Corporation, 800-542-2307, [email protected], https://www.rolanddga.com

SOURCE Roland DGA Corporation